ÅǸ޴º
Á¦¸ñ | Targeted sequencing identifies genetic alterations that confer Primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium) | µî·ÏÀÏ | 20160504 | ´Ù¿î·Îµå | |
---|---|---|---|---|---|
Targeted sequencing identifies genetic alterations that confer Primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium). ONCOTARGET 2016 Apr 21. doi: 10.18632/oncotarget.8904.
|
Copyright ¨Ï chamc, All rights reserved.